INCYTE PHARMACEUTICALS INC
10-Q/A, 1998-01-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: PRUDENTIAL PACIFIC GROWTH FUND INC, 24F-2NT, 1998-01-14
Next: HEALTH PROFESSIONALS INC /DE, 10-K, 1998-01-14






                                 UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

                                  FORM 10-Q/A


[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
     EXCHANGE  ACT  OF  1934

               For the quarterly period ended September 30, 1997

                                      or


[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
     EXCHANGE  ACT  OF  1934

For the transition period from _________________to___________________


                       Commission File Number:  0-27488

                         INCYTE PHARMACEUTICALS, INC.
            (Exact name of registrant as specified in its charter)

          Delaware                              94-3136539
          --------                              ----------
(State  or  other  jurisdiction  of      (IRS Employer Identification No.)
incorporation  or  organization)

                               3174 Porter Drive
                         Palo Alto, California  94304
                   (Address of principal executive offices)

                                (650) 855-0555
             (Registrant's telephone number, including area code)

Indicate  by  check  mark  whether  the  registrant  (1) has filed all reports
required  by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding  12  months (or for such shorter period that the registrant was
required  to  file  such  reports),  and  (2)  has been subject to such filing
requirements  for  the  past  90  days.
[X]  Yes   [  ]  No

The  number of outstanding shares of the registrant's Common Stock, $0.001 par
value,  was  24,026,402  as  of  October  31,  1997.


<PAGE>  2
<TABLE>
<CAPTION>

                               INCYTE PHARMACEUTICALS, INC.

                                          INDEX







PART II: OTHER INFORMATION
- -----------------------------------------------------------------------------------      
<S>                                                                                  <C>

ITEM 6  Exhibits and Reports on Form 8-K. . . . . . . . . . . . . . . . . . . . . .     3

             Signatures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     4

             Exhibit Index. . . . . . . . . . . . . . . . . . . . . . . . . . . . .     5
</TABLE>




<PAGE>  3

PART  II:      OTHER  INFORMATION




ITEM  6  Exhibits  and  Reports  on  Form  8-K.

         a)  Exhibits
             See  Exhibit  Index  on  Page  5

         b)  Reports  on  Form  8-K
             None

<PAGE>  4




Pursuant  to  the  requirements  of  the  Securities Exchange Act of 1934, the
registrant  has  duly  caused  this  report  to be signed on its behalf by the
undersigned  thereunto  duly  authorized.


                                                  INCYTE PHARMACEUTICALS, INC.



Date:  January 13, 1998                 By:  /s/Roy  A.  Whitfield
                                             --------------------------------
                                             Roy A. Whitfield
                                             Chief Executive Officer


Date:  January 13, 1998                 By:  /s/Denise M. Gilbert
                                             --------------------------------
                                             Denise M. Gilbert
                                             Executive Vice President and
                                                 Chief Financial Officer

<PAGE>  5


                         INCYTE PHARMACEUTICALS, INC.

                                 EXHIBIT INDEX



<TABLE>
<CAPTION>



    NO.    EXHIBIT                                                       PAGE
    -----  ----------------------------------------------------          -----

<S> <C>     <C>                                                          <C>

    10.18   Master Strategic Relationship Agreement dated as of 
            September 2, 1997 between SmithKline Beecham Corporation,
            Incyte Pharmaceuticals, Inc. and diaDexus, LLC. + . .  . . .  6         







</TABLE>


_____________
+   Confidential treatment has been requested with respect to certain portions
    of  this  Agreement.




<PAGE> 6

                                                               EXHIBIT 10.18

CONFIDENTIAL TREATMENT REQUESTED.  CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE 
BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.




                    MASTER STRATEGIC RELATIONSHIP AGREEMENT
                                  dated as of
                               September 2, 1997
                                    between

                        SMITHKLINE BEECHAM CORPORATION,
                         INCYTE PHARMACEUTICALS, INC.
                                      and
                                 DIADEXUS, LLC


<PAGE> 7
<TABLE>
<CAPTION>



<S>  <C>                                                        <C>
                               TABLE OF CONTENTS
                               -----------------                

ARTICLE 1.   CERTAIN DEFINITIONS.................................1

1.1.  Certain Definitions........................................1
                   
ARTICLE 2.   THE TRANSACTIONS....................................7

2.1.  Formation of LLC, Etc......................................7
2.2.  Excluded Liabilities.......................................8
                   
ARTICLE 3.   TRANSITIONAL MATTERS

3.1.  Certain Tax Matters........................................8
3.2.  Exemption Certificate......................................8
                   
ARTICLE 4.   REPRESENTATIONS AND WARRANTIES OF INCYTE............8

4.1.  Corporate Organization and Authority.......................8
4.2.  No Conflict................................................9
4.3.  Approvals and Consents.....................................9
4.4.  Litigation.................................................9
4.5.  Broker's and Finder's Fees.................................9
4.6.  Full Disclosure............................................9
                   
ARTICLE 5.   REPRESENTATIONS AND WARRANTIES OF SB...............10

5.1.  Corporate Organization and Authority......................10
5.2.  No Conflict...............................................10
5.3.  Approvals and Consents....................................10
5.4.  Title to Assets...........................................11
5.5.  Litigation................................................11
5.6.  Compliance with Applicable Laws...........................11
5.7.  SB Employees..............................................11
5.8.  Broker's and Finder's Fees................................11
5.9.  Full Disclosure...........................................11
                   
ARTICLE 6.   COVENANTS OF THE PARTIES...........................12

6.1.  Additional Cash Contributions.............................12
6.2.  Merger of the LLC into C Corporation......................12
6.3.  Coordination of Financial Reporting.......................14
6.4.  Additional Financing......................................15
                   
ARTICLE 7.   EMPLOYEES AND EMPLOYEE BENEFITS....................15

7.1.  Offers of Employment......................................15
7.2.  Benefits..................................................15
<PAGE>  8

7.3.  Severance Pay.............................................15
7.4.  Relocation Expenses.......................................16
7.5.  Wages, Benefits, Etc......................................16
7.6.  Payment of Claims.........................................16
7.7.  Secondment of Employees...................................16
7.8.  Continuing Employees......................................17
                   
ARTICLE 8.   CLOSING PROCEDURE..................................17

8.1.  Closing Date and Place....................................17
                   
ARTICLE 9.   INDEMNIFICATION....................................17

9.1.  Indemnification...........................................17
9.2.  Procedure for Indemnification.............................19
                   
ARTICLE 10.  MISCELLANEOUS......................................20

10.1. Survival..................................................20
10.2. No Commitments............................................21
10.3. Assignments...............................................21
10.4. Confidentiality...........................................22
10.5. Intentionally Omitted.....................................23
10.6. Observance of Separate Entity Formalities.................23
10.7. Certain Dissolution Matters...............................24
10.8. Further Actions...........................................25
10.9. No Trademark Rights.......................................25
10.10.Entire Agreement of the Parties; Amendments...............25
10.11.Severability..............................................25
10.12.Captions..................................................25
10.13.Applicable Law............................................26
10.14.Disclaimer................................................26
10.15.Notices and Deliveries....................................26
10.16.Counterparts..............................................27
10.17.Construction of Agreement.................................27
10.18.Expenses..................................................28
10.19.Force Majeure.............................................28
10.20.Affiliate Performance.....................................28
10.21.Dispute Resolution........................................28
10.22.Relationship Between Parties..............................29
10.23.Third Party Beneficiaries.................................29
10.24.Certain Transfer Matters..................................29
</TABLE>



<PAGE>  9


                    MASTER STRATEGIC RELATIONSHIP AGREEMENT
                    ---------------------------------------

     THIS  MASTER STRATEGIC RELATIONSHIP AGREEMENT (the "Agreement"), dated as
of  September  2,  1997,  among SMITHKLINE BEECHAM CORPORATION, a Pennsylvania
corporation  ("SB"),  INCYTE  PHARMACEUTICALS,  INC.,  a  Delaware corporation
("Incyte"),  and  DIADEXUS,  LLC,  a  Delaware  limited liability company (the
"LLC").
                                  
                                    RECITALS

     A.   SB  is  a  Pennsylvania corporation with a principal place of
business  located  at  709  Swedeland  Road,  King  of  Prussia, Pennsylvania.
     
     B.   Incyte is a Delaware corporation with a principal place of business
located  at  3174  Porter  Drive,  Palo  Alto,  California.
     
     C.   Incyte and SB wish to form a limited liability company under the laws
of  the  State of Delaware (the "LLC"), the sole initial members of which will
be  SB  and Incyte.  Incyte and SB will contribute certain cash and assets and
will  agree  to  manage  the operations of the LLC on the terms and conditions
hereinafter  provided  and  as  set  forth  in  the  LLC  Operating Agreement.

     NOW,  THEREFORE, in consideration of their mutual promises and obligations 
and intending  to  be  legally  bound  hereby,  the  parties  agree  as  
follows:
                                     
                                   ARTICLE 1.
                                   ----------
                               CERTAIN DEFINITIONS
                               -------------------  

     1.1.   CERTAIN  DEFINITIONS.
     ----------------------------
     As  used  in  this Agreement, the terms below shall have the meanings set
forth.

     "Agreement"  means this Master Strategic Relationship Agreement, including 
all Schedules  hereto,  as  modified,  amended  or extended in accordance with 
the terms  hereof  from  time  to  time.

     "agreement"  shall  mean  with  respect to any Person any contract, 
agreement, arrangement,  commitment,  covenant,  lease,  license,  note, bond, 
indenture, mortgage,  deed  of  trust,  lien,  instrument or other 
understanding, whether written or oral, to which such Person is a party or by 
which its properties or assets  may  be  subject  or  affected  or  under  
which  it  or its business, properties  or  assets  receive  benefits.

     "Applicable  Law"  means  any  statute, law, enactment, ordinance, common 
law, rule  or  regulation  of  any Governmental Authority and any judgment, 
decree, injunction, mandate, administrative or executive order or other order 
(whether temporary,  preliminary  or  permanent)  
<PAGE> 10

entered  or imposed by a Governmental Authority  that  is applicable to Incyte, 
SB, the LLC or any Incyte Affiliate, SB  Affiliate  or  LLC  Affiliate,  as 
the case  may  be.

     "Bankruptcy"  shall  mean  with respect to any Person (A) the entry by a 
court having  jurisdiction  in  the  premises of (i) a decree or order for 
relief in respect  of  such  Person  in  an  involuntary  case  or  proceeding 
under any applicable  federal  or  state bankruptcy, insolvency, reorganization 
or other similar  law  or  (ii)  a  decree or order adjudging such Person a 
bankrupt or insolvent,  or  approving as properly filed a petition seeking 
reorganization, arrangement,  adjustment  or composition of or in respect of 
such Person under any Applicable Law, or appointing a custodian, receiver, 
liquidator, assignee, trustee,  sequestrator  or  other  similar  official  of 
such Person or of any substantial  part  of  such  Person's  property, or 
ordering the winding up or liquidation  of  the  affairs  of  such Person and 
the continuance of any such decree  or  order for relief or any such other 
decree or order unstayed and in effect  for  a  period  of 90 consecutive days 
or (B) the commencement by such Person of a voluntary case or proceeding under 
any applicable federal or state bankruptcy,  insolvency,  reorganization  or 
other similar law or of any other case  or  proceeding to be adjudicated a 
bankrupt or insolvent, or the consent by such Person to the entry of a decree
or order for relief in respect of such Person  in  an  involuntary case or 
proceeding under any applicable federal or state  bankruptcy,  insolvency, 
reorganization or other similar law or to the commencement of any bankruptcy or 
insolvency case or proceeding against it, or the  filing  by  such  Person  of  
a  petition  or  answer  or consent seeking reorganization  or  relief  under  
any  Applicable Law, or the consent by such Person  to  the  filing  of  such  
petition or to the appointment of or taking possession  by  a  custodian,  
receiver,  liquidator,  assignee,  trustee, sequestrator  or similar 
official of such Person or of any substantial part of such  Person's property,
or the making by such Person of an assignment for the benefit  of  creditors,
or  the  admission  by  such  Party in writing of its inability  to  pay  its 
debts  generally as they become due, or the taking of corporate  or  other 
action by such Person in furtherance of any such action.

     "Business"  means  the  business of discovering, developing, manufacturing 
and marketing  molecular  diagnostic  Tests (as defined in the IP Agreements), 
and doing  all  things necessary or related to these purposes as may be 
determined from  time  to time by the LLC in accordance with the LLC Operating 
Agreement.

     "Business  Day"  means  any  day other than Saturday, Sunday or a day on 
which banking  institutions  in San Francisco, California and New York, New 
York are required  or  authorized  to  be  closed.

     "Change  of  Control" means with respect to either Incyte or SB the 
occurrence of  any  of  the  following  events:

     (a) all or substantially all of the assets of the Incyte or SB, as the
         case may be, are sold, leased, exchanged or otherwise transferred to
         any other Person  or  group of Persons acting in concert as a 
         partnership or other group (a  "Group  of  Persons")  other  than  an 
         affiliate  of  Incyte  or  SB;

     (b) the Ultimate Parent Company of Incyte or SB, as the case may be,
         is merged  or  consolidated  with or into another entity with the
         effect that the 
<PAGE> 11

         existing equity holders hold less than 50% of the 
         combined voting power of the then  outstanding  securities  ordinarily 
         (and apart from rights arising under special  circumstances)  having 
         the right to vote in the election of directors (or in the election of 
         persons serving in a similar capacity) of the surviving entity  of  
         such  merger  or  the  entity  resulting  from such consolidation;

     (c) a change in the composition of the board of directors of the Ultimate
         Parent  Company  of  Incyte  or  SB,  as the case may be, as a result
         of which during  any  period of two consecutive years, individuals who 
         at the beginning of  such  period  constitute such Ultimate Parent 
         Company's Board of Directors(together  with  any  new  director  whose
         election  by  such Ultimate Parent Company's Board of Directors or   
         whose nomination for election by such Ultimate Parent Company's
         stockholders was approved by a vote of at least two-thirds of the   
         directors then still in office who either were directors at the 
         beginning of  such period or whose election or nomination for election 
         was previously so approved)  cease  for  any reason to constitute a 
         majority of the directors in office  at  the  end  of  such  period;

     (d) a  Person  or  Group of Persons shall, as a result of a tender or
         exchange  offer, open market purchases, merger, privately negotiated 
         purchases or  otherwise,  have  become,  directly  or  indirectly,
         the beneficial owner(within  the  meaning of Rule 13d-3 under the 
         Securities Exchange Act of 1934,as  amended) of the securities of the 
         Ultimate Parent Company of Incyte or SB,as  the  case may be, 
         representing 50% or more of the combined voting power of
         the  then  outstanding  securities  of such Ultimate Parent Company  
         ordinarily(and  apart  from rights arising under special
         circumstances) having the right to  vote  in  the  election  of  
         directors.
     
     "Closing"  shall  have  the  meaning  set  forth  in  Section  8.1.

     "Code"  means  the  Internal  Revenue  Code  of  1986,  as  amended.

     "Encumbrances"  means  any  claims,  charges,  liens,  mortgages,  security
interests, pledges, restrictions, rights of first refusal, options, easements,
encroachments  or  other  encumbrances.

     "Equipment"  means  the  equipment listed on Schedule 1.1(a), that is 
owned by SB, and which the parties have agreed shall be contributed to the 
LLC and used in  conducting  the  Business.  All items of the Equipment have
as of the date hereof  the  book value indicated on such Schedule and shall
be contributed to the  LLC.    Title for such Equipment shall pass to the LLC
on the date of the formation  of the LLC and SB shall bear the cost of 
shipping such Equipment to the LLC's facilities in California and the risk of 
loss until delivery of such Equipment  at  the  LLC's  facilities  in  
California.

     "ERISA" means the Employee Retirement Income Security Act of 1974, as 
amended.
<PAGE>  12

     "Governmental  Authority"  means  the  government of the United States, 
United Kingdom  or  other foreign nation or any state or political subdivision 
of any of  the  foregoing and any entity exercising executive, legislative, 
judicial, regulatory  or  administrative  functions  of  or  pertaining  to  
government.

     "Governmental  Consents"  means,  with  respect  to any party, such 
approvals, permits,  authorizations,  registrations,  waivers or consents of 
Governmental Authorities  as  are  necessary or appropriate to be obtained by 
such party in order  to permit the execution, delivery and performance of this 
Agreement and the  consummation  of  the  transactions  contemplated  herein.

     "HSR  Act"  means the Hart-Scott-Rodino Antitrust Improvements Act of
1976, as amended,  and  any  rules  or  regulations  promulgated  thereunder. 

     "Incyte  Affiliate":  shall  mean  any corporation, firm, partnership or 
other entity  (other  than  the LLC), whether de jure or de facto, which 
directly or indirectly  owns,  is owned by or is under common ownership with 
Incyte to the extent  of  at  least  fifty  percent  (50%)  of  the  equity
(or such lesser percentage  which  is the maximum allowed to be owned by a 
foreign corporation in  a  particular  jurisdiction)  having  the  power  to
vote on or direct the affairs of the entity, and any person, firm, 
partnership, corporation or other entity  actually  controlled  by,  
controlling  or  under  common control with Incyte.

     "Incyte's  knowledge"  or other similar phrases means to the actual 
knowledge, after  reasonable investigation, of Incyte's officers who have had 
substantive responsibilities  with  respect  to  the  matter  described.

     "Indemnified  Party"  shall  have  the  meaning  set  forth  in  Section  
9.2.

     "Indemnitor"  shall  have  the  meaning  as  set  forth  in  Section  9.2.

     "Intercompany  Services  Agreement"  shall  mean  that  certain  
Intercompany Services Agreement referred to in Section 2.1, as the same may be 
amended from time  to  time.

     "Interests"  shall have the meaning as defined in the LLC Operating 
Agreement.

     "IP  Agreements"  shall  mean,  collectively  [                 

                                                                           ]

     "Legal  Proceeding"  means  any  actions,  suits,  claims  or  proceedings.
<PAGE>  13    

     "Liabilities"  means  any  debt,  obligation,  duty or liability of any 
nature (including  any  unknown,  undisclosed,  unmatured,  unaccrued,  
unasserted, contingent,  implied,  derivative  or  secondary  liability).

     "LLC  Affiliate" shall mean any corporation, firm, partnership, or other 
legal entity, which is directly or indirectly owned or under common ownership
by the LLC  to the extent of which the common stock or other equity ownership 
thereof is  one  hundred percent (100%) owned by the LLC; provided however,
that where local  laws require a minimum percentage of local ownership, the
status of the LLC  Affiliate  will  be established if the LLC directly or 
indirectly owns or controls  one  hundred percent (100%) of the maximum 
ownership percentage that may,  under  such  local  laws,  be  owned or 
controlled by foreign interests.

     "LLC Operating Agreement" means that certain Operating Agreement for 
DiaDexus, LLC,  entered  into  among  Incyte, SB and the other parties thereto 
as of the date  hereof,  as  the  same  may  be  amended  from  time  to  time.

     "LLC  Option  Plan"  means  the  Incentive  Plan  to  be  adopted  by the 
LLC.

     "Losses" means all assessments, losses, damages, costs, expenses, 
liabilities, judgments,  awards,  fines, sanctions, penalties, charges, and 
amounts paid in settlement  including  reasonable  costs,  fees  and  expenses  
of  attorneys, experts,  accountants,  appraisers,  consultants, witnesses, 
investigators and any  other agents and shall include all such costs, fees and 
expenses incurred by an Indemnified Party in successfully enforcing its right
to indemnification hereunder.

     "Material  Adverse  Effect"  means  a material adverse effect on the 
business, financial condition, results of operations or prospects of the 
Business or the LLC.

     "Person"  means any individual, partnership, joint venture, corporation, 
trust or unincorporated organization, any other business entity and any 
Governmental Authority.

     "Related  Agreements"  shall  mean  the  LLC  Operating  Agreement,  the  
IP Agreements,  the  Intercompany  Services  Agreement  and  all  other  written
agreements  entered  into  in connection with the transactions contemplated by
this  Agreement,  as  the  same  may  be  amended  from  time  to  time.

     "Reporting  Entity"  shall  have  the  meaning  set  forth  in  Section  
6.3.

     "SB  Affiliate"  shall mean any corporation, firm, partnership or other 
entity(other  than  the  LLC),  whether  de  jure  or  de  facto,  which 
directly or indirectly  owns,  is  owned  by  or  is under common ownership
with SB to the extent  of  at  least  fifty  percent  (50%)  of  the  equity
(or such lesser percentage  which  is the maximum allowed to be owned by a 
foreign corporation in  a  particular  jurisdiction)  having  the  power  
to vote on or direct the affairs of the entity, and any person, firm, 
partnership, corporation or other entity  actually  controlled  by, 
controlling or under common control with SB.

<PAGE>  14
     "SB Employees" means the individuals who are full-time employees of SB who 
are listed  with their respective titles on Schedule 1.1(b), each of whom shall 
be offered full-time employment with the LLC in accordance with Article 7 
hereof.

     "SB's knowledge" or other similar phrases means to the actual knowledge, 
after reasonable  investigation,  of  SB's  officers  who  have  had  
substantive responsibilities  with  respect  to  the  matter  described.

     "Taxes"  means  taxes,  duties,  levies  and  other assessments imposed by 
any Governmental  Authority or by any other tax authority, including income, 
gross receipts,  net  proceeds,  ad  valorem,  turnover,  real and personal 
property (tangible  and intangible), sales, use, franchise, excise, value 
added, stamp, leasing,  lease,  user,  transfer,  fuel,  excess  profits,  
occupational and interest  equalization,  windfall  profits,  severance  and
employees' income withholding  and Social Security taxes, including all 
applicable penalties and interest.

     "Tax  Return" means any report, return, document or other information 
required to  be  filed  with  or  supplied to a tax authority in connection 
with Taxes.

     "Transferring  Employees"  means  those  of  the  SB  Employees  that  
accept employment  with  the  LLC.

     "Ultimate Parent Company" shall mean with respect to Incyte or SB, that 
entity that  has  beneficial  ownership  (within  the meaning of Rule 13d-3 
under the Securities Exchange Act of 1934, as amended) of voting securities 
representing 50%  or  more  of the combined voting power of the then 
outstanding securities having  the  right  generally to vote in the election
of directors (apart from rights  to  vote  in  the  election  of  directors
arising  under special circumstances)  of  Incyte  or  SB, as the case may 
be, or if there is no such entity,  then  Incyte  or  SB,  as  the  case  may 
be.  As of the date of this Agreement,  the  Ultimate  Parent  Company  for
SB  is  SB  plc.

     "Unreimbursed LLC Liability" shall mean a Liability of the LLC that is for 
any reason  paid  by  either  of  Incyte,  or  SB,  or  any Incyte Affiliate or 
SB Affiliate,  which  Liability  is not for any reason subsequently reimbursed 
to the party that has paid it unless and solely to the extent that such 
Liability is  by  the  terms  of  this Agreement or any Related Agreement 
assumed by the paying  party.
<PAGE>  15                                 

                                   ARTICLE 2.
                                   ----------
                                THE TRANSACTIONS
                                ----------------

     2.1.   FORMATION  OF  LLC,  ETC.
     --------------------------------
     Subject  to  the terms and conditions set forth in this Agreement, at the
Closing,  the following actions shall be taken concurrently with the execution
of  this  Agreement  with  respect  to  the  formation  of  the  LLC:

     (a) Incyte  and  SB  shall execute and deliver the LLC Operating
Agreement  with  such  changes as each of them shall agree are consistent with
the  terms of this Agreement and file all such certificates and filings as may
be required to be filed with the Secretary of State for the State of Delaware.
SB  and  Incyte shall receive[                                                
                          ],  respectively,  of  the LLC upon its formation in
consideration for which they shall each make their respective contributions to
the  LLC  contemplated  by this Section 2.1 and by Sections 6.1(a) and 6.1(b);

     (b) Incyte shall make an initial contribution to the LLC [             ];

     (c) SB shall make an initial contribution to the LLC [                 ];

     (d) Incyte  and  SB  shall deposit the full amount of additional cash
contributions  required  by  Sections  6.1(a)  and  (b)  into  separate escrow
accounts  pursuant  to  Section  6.1(d);

     (e) the  LLC, SB and Incyte shall execute and deliver those of the IP
Agreements  to  which each of them is a party with such changes as each of the
applicable  parties  shall  agree  are  consistent  with  the  terms  of  this
Agreement;

     (f) the  LLC, SB and Incyte shall execute and deliver an Intercompany
Services  Agreement  (the  "Intercompany Services Agreement") (which agreement
among  other  things  entitles  Incyte and SB to receive payment for providing
certain  services  that may be performed by each of them from time to time for
the  benefit  of  the  LLC with respect to tax, accounting and other specified
operational  matters  for  which  the LLC requests support from time to time),
with  such  changes as SB and Incyte shall agree are consistent with the terms
of  this  Agreement;  and

     (g) the  LLC,  SB and Incyte shall execute and deliver a copy of this
Agreement.
<PAGE> 16
     
     2.2.   EXCLUDED  LIABILITIES.
     -----------------------------
     The  LLC  shall  not be deemed to have assumed or be responsible for, and
shall  not  assume  or  be  responsible  for,  any  Liabilities  of SB, any SB
Affiliates,  Incyte  or  any  Incyte  Affiliates.
 

                                   ARTICLE 3.
                                   ----------
                              TRANSITIONAL MATTERS
                              --------------------
     3.1.   CERTAIN  TAX  MATTERS.
     -----------------------------
     After  the  Closing,  SB,  Incyte  and  the  LLC will provide any and all
information  reasonably  required  by  the  other  parties  for the purpose of
fulfilling  the  other  parties'  foreign,  federal  and  state  tax reporting
obligations  with  respect  to  the  Equipment  or  with  respect to any other
pertinent tax matter (whether for the periods before or after the Closing) for
which  any  other  party  may  reasonably  require  such  information.
     
     3.2.   EXEMPTION  CERTIFICATE.
     ------------------------------
     In  connection with the contribution of the Equipment to the LLC, the LLC
shall  provide  to  SB  a  completed  Pennsylvania Exemption Certificate, Form
REV-1220AS, evidencing its eligibility to make tax-free purchases of machines,
equipment,  parts,  and supplies used or consumed directly in manufacturing or
processing  operations.


                                     ARTICLE 4.
                                     ----------
                       REPRESENTATIONS AND WARRANTIES OF INCYTE
                       ----------------------------------------
     Incyte  hereby  represents  and  warrants  to  SB  that:
     
     4.1.   CORPORATE  ORGANIZATION  AND  AUTHORITY.
     -----------------------------------------------
     (a) Incyte is a corporation, duly organized, validly existing and in
good standing under the laws of the State of Delaware.  Incyte is qualified to
do business and is in good standing under the laws of the State of California.

     (b) Subject to obtaining any Governmental Consents required to be obtained
by  Incyte, Incyte has the right, power and authority and has taken all action
necessary  in order to execute, deliver and perform its obligations under this
Agreement  and  the LLC Operating Agreement and to consummate the transactions
contemplated  hereby  and  thereby.    This  Agreement  and  the LLC Operating
Agreement  are  legal,  valid  and  binding  agreements of Incyte, enforceable
against Incyte in accordance with their respective terms, except as limited by
bankruptcy,  insolvency,  reorganization,  fraudulent transfer, moratorium and
similar  laws  affecting  the  rights  of  creditors  generally  and  by  the
availability  of  equitable  remedies.
<PAGE>  17    

     4.2.   NO  CONFLICT.
     --------------------
     The  execution,  delivery  and  performance of this Agreement and the LLC
Operating  Agreement  by  Incyte  does  not,  and  the  consummation  of  the
transactions  contemplated  hereby  and thereby will not (i) violate, conflict
with  or  result  in  a  breach  of  any  provision  of  its  Certificate  of
Incorporation  or Bylaws or (ii) conflict with, violate or constitute a breach
or  contravention  of, or default under, any Applicable Law to which Incyte is
subject  or (iii) conflict with, violate or constitute a breach of, or default
under,  or  otherwise  give  rise to any right of termination, cancellation or
acceleration  on  the  part of, or otherwise require the consent of any Person
under, any agreement or instrument to which Incyte is subject or is a party or
by  which  Incyte    is  otherwise  bound.
     
     4.3.   APPROVALS  AND  CONSENTS.
     -------------------------------
     Except  to  the  extent that filings may be required under the HSR Act in
connection  with  any  merger of the LLC contemplated under Section 6.2, there
are  no Governmental Consents required to be obtained by Incyte from any other
Person  in  connection  with  the  execution, delivery and performance of this
Agreement  or  the  LLC  Operating Agreement by Incyte and the consummation by
Incyte  of  the  transactions  contemplated  hereby  and  thereby  other  than
Governmental Consents which have been previously obtained.  Neither Incyte nor
any  of  the  Incyte  Affiliates has received any indication from any federal,
state  or  other governmental agency that such agency would refuse to grant or
issue  any  Governmental  Consent required to be obtained by SB, Incyte or any
Incyte  Affiliates  or  SB  Affiliates  in  connection  with  the transactions
contemplated  by  this  Agreement  and  the  LLC  Operating  Agreement.
     
     4.4.   LITIGATION.
     -----------------
     There  are  no  Legal  Proceedings  pending  or,  to  Incyte's knowledge,
threatened,  or,  to  Incyte's  knowledge,  any  investigations  pending  or
threatened,  against  or involving Incyte (i) relating to the formation of the
LLC,  or  (ii)  that  challenge,  or  that  may have the effect of preventing,
delaying,  making  illegal,  or  otherwise  interfering  with,  any  of  the
transactions  contemplated  by  this Agreement or the LLC Operating Agreement.
     
     4.5.   BROKER'S  AND  FINDER'S  FEES.
     ------------------------------------
     Neither Incyte nor any of the Incyte Affiliates, nor anyone acting on its
behalf  has  paid  or  become  obligated  to  pay any fee or commission to any
broker,  finder,  intermediary,  financial advisor or other Person (other than
legal  and  accounting  advisors)  in  connection  with  the  transactions
contemplated  hereby,  and no Person or entity is entitled to receive from any
of  them any such fee or commission which SB or any of the SB Affiliates would
become  obligated  to  pay.
     
     4.6.   FULL  DISCLOSURE.
     -----------------------
     No representation or warranty by Incyte in this Agreement, in any Related
Agreement,  any  Schedule  hereto  or  thereto,  or  any  statement,  list  or
certificate  furnished or to be furnished by 
<PAGE>  18

Incyte pursuant to this Agreementor  any  Related Agreement as of the date 
hereof (i) is materially inaccurate,or  (ii)  contains  any  untrue  statement 
of material fact, or (iii) omits to state  a  material fact required to be 
stated therein or necessary to make the statements  contained  therein not 
misleading in light of the circumstances in which  made.


                                     ARTICLE 5.
                                     ----------
                        REPRESENTATIONS AND WARRANTIES OF SB
                        ------------------------------------
     SB  hereby  represents  and  warrants  to  Incyte  that:
    
     5.1.   CORPORATE  ORGANIZATION  AND  AUTHORITY.
     -----------------------------------------------
     (a) SB is a corporation, duly organized, validly existing and in good
standing  under  the  laws  of  the  Commonwealth of Pennsylvania.  SB has the
requisite corporate power and corporate authority to own the Equipment held by
it.

     (b) Subject to obtaining any Governmental Consents required to be obtained 
by  SB,  SB  has  the  requisite  right, power and authority and has taken all 
action  necessary  in order to execute, deliver and perform this Agreement and 
the  LLC  Operating  Agreement and to consummate the transactions contemplated 
hereby and thereby.  This Agreement and the LLC Operating Agreement are legal, 
valid  and  binding agreements of SB enforceable against SB in accordance with 
their  respective  terms,  except  as  limited  by  bankruptcy,  insolvency, 
reorganization,  fraudulent  transfer,  moratorium  and similar laws affecting 
creditors  generally  and  by  the  availability  of  equitable  remedies.
     
     5.2.   NO  CONFLICT.
     --------------------    
     The  execution,  delivery  and  performance of this Agreement and the LLC
Operating  Agreement  by SB does not, and the consummation of the transactions
contemplated hereby and thereby will not, (i) violate, conflict with or result
in a breach of any provision of SB's Articles of Incorporation or Bylaws, (ii)
conflict  with, violate or constitute a breach or contravention of, or default
under,  any  Applicable Law to which SB or any of the Equipment is subject, or
(iii)  conflict  with, violate or constitute a breach of, or default under, or
otherwise  give rise to any right of termination, cancellation or acceleration
of,  or  otherwise  require  the consent of any Person under, any agreement or
instrument  to which SB or any of the Equipment is subject or is a party or by
which  SB  or  any  of  the  Equipment  is  otherwise  bound.
     
     5.3.   APPROVALS  AND  CONSENTS.
     --------------------------------
     Except  to  the  extent that filings may be required under the HSR Act in
connection  with  any  merger of the LLC contemplated under Section 6.2, there
are  no  Governmental  Consents  required  to be obtained by SB from any other
Person  in  connection  with  the  execution, delivery and performance of this
Agreement  and the LLC Operating Agreement by SB and the consummation by SB of
the  transactions  contemplated  hereby  and  thereby  other than 
<PAGE>  19

Governmental Consents  which  have  been previously obtained.  Neither SB nor 
any of the SB Affiliates  has  received  any  indication  from  any  federal, 
state or other governmental  agency  that  such  agency  would  refuse  to 
grant or issue any Governmental  Consent  required  to  be  obtained  by SB,
Incyte or any Incyte Affiliates  or  SB Affiliates in connection with the 
transactions contemplated by  this  Agreement  and  the  LLC  Operating  
Agreement.
     
     5.4.   TITLE  TO  ASSETS.
     ------------------------
     SB  has  and  shall  transfer to the LLC good and marketable title to the
Equipment  free  and  clear  of  all  Encumbrances.
     
     5.5.   LITIGATION.
     -----------------
     There are no Legal Proceedings pending or, to SB's knowledge, threatened,
or,  to  SB's  knowledge, any investigations pending or threatened, against or
involving  SB,  (i)  relating to the formation of the LLC or the Equipment, or
(ii)  that  challenge,  or  that  may have the effect of preventing, delaying,
making  illegal,  or  otherwise  interfering  with,  any  of  the transactions
contemplated  by  this  Agreement  or  the  LLC  Operating  Agreement.
     
     5.6.   COMPLIANCE  WITH  APPLICABLE  LAWS.
     -----------------------------------------
     SB  is  in  compliance  with  all Applicable Laws relating to each of the
Equipment,  except  for  failures  to  comply  which  individually  or  in the
aggregate  would not reasonably be expected to have a Material Adverse Effect.
     
     5.7.   SB  EMPLOYEES.
     --------------------
     Schedule  1.1(b)  contains  a  true  and  complete list of each of the SB
Employees,  together  with  the  job  title  of  each  such  SB  Employee.
     
     5.8.   BROKER'S  AND  FINDER'S  FEES.
     ------------------------------------
     Neither  SB  nor  any  of  the  SB Affiliates, nor anyone acting on their
behalf,  has  paid  or  become  obligated  to pay any fee or commission to any
broker,  finder,  intermediary,  financial advisor or other Person (other than
legal  and  accounting  advisors)  in  connection  with  the  transactions
contemplated hereby and no Person or entity is entitled to receive from any of
them  any  such fee or commission which Incyte or any of the Incyte Affiliates
would  become  obligated  to  pay.
     
     5.9.   FULL  DISCLOSURE.
     -----------------------
     No  representation  or  warranty  by SB in this Agreement, in any Related
Agreement,  any  Schedule  hereto  or  thereto,  or  any  statement,  list  or
certificate  furnished  or to be furnished by SB pursuant to this Agreement or
any  Related  Agreement as of the date hereof (i) is materially inaccurate, or
(ii) contains any untrue statement of material fact, or (iii) omits to state a
material  fact  required  to  be  stated  therein  or  necessary  to  make the
statements  contained  therein not misleading in light of the circumstances in
which  made.
<PAGE>  20


                                     ARTICLE 6.
                                     ----------
                              COVENANTS OF THE PARTIES
                              ------------------------
     6.1.   ADDITIONAL  CASH  CONTRIBUTIONS.
     ---------------------------------------
     (a) SB  Additional  Contributions.
          
          (i)    [                                                    ].

          (ii)   [                                                    ]. 

     (b)  Incyte  Additional  Contributions.

          (i)    [                                                    ].

          (ii)   [                                                    ].
     
     (c)  [
                                                           ].

     (d) Escrow of Funds or Security for Payment.  Upon formation of the LLC,
all  of  the  cash  contribution payments set forth in Sections 6.1(a) and (b)
shall be deposited into separate escrow accounts on terms satisfactory to each
of  Incyte  and SB that provide for the unconditional release of such funds to
the LLC on the dates specified above unless the parties shall otherwise agree.
All  funds  in  each escrow account shall be segregated and interest earned on
any  funds so deposited shall be for the account of, and shall be returned to,
whichever of Incyte or SB deposited the funds earning such interest.  Upon any
termination  of  contribution  obligations  pursuant  to  Section  6.1(c), all
remaining funds in each escrow account together with applicable interest shall
be  returned  to  the  contributing party with respect to such escrow account.
     
     6.2.   MERGER  OF  THE  LLC  INTO  C  CORPORATION.
     -------------------------------------------------
     (a) Timing.   The LLC shall merge into a "C" corporation (the "C
Corporation")  upon  the earliest to occur of the following:  [       
<PAGE>  21

                                                    ]; or (iii) at such other
time as Incyte and SB may agree; provided that such merger in the case of (ii)
above  shall  not  be  required  until  [               ] unless SB and Incyte
otherwise  agree.  In any such case such merger shall be accomplished by means
of  the  following  unless  otherwise  agreed  by  SB  and  Incyte:

          (i)   The parties shall incorporate the C Corporation pursuant to the 
                laws of  the  State  of  Delaware,  by  adopting  a  Certificate
                of  Incorporation substantially  in  the  form  attached hereto 
                as Part I of Schedule 6.2(a) and Bylaws  substantially  in  
                the form attached  as Part II of Schedule 6.2(a).

          (ii)  The C Corporation, Incyte and SB shall execute an Investors' 
                Rights Agreement  substantially  in  the form attached hereto
                as Part III of Schedule 6.2(a).

          (iii) Upon such merger, the C Corporation shall issue to SB (A) a 
                number of  shares  of  its  Series  A Preferred Stock equal to 
                the number of Series A Preferred Units (as defined in the LLC 
                Operating Agreement) held by SB and (B) 100 shares of its 
                Common Stock as consideration for SB's Interests in the LLC.

          (iv)  Upon  such merger, the C Corporation shall issue to Incyte (A) a
                number of shares of its Series B Preferred Stock equal to the 
                number of Series B  Preferred  Units (as defined in the LLC 
                Operating Agreement) held by Incyte and (B) 100 shares of its
                Common Stock as consideration for Incyte's Interests in  the  
                LLC.

          (v)  Pursuant to the merger, the C Corporation shall issue replacement
               options  to  the employees  of  the  LLC who hold options 
               pursuant to the LLC Option  Plan  (the "LLC Options").  Such 
               replacement options shall entitle the holder  thereof to acquire 
               shares of the C Corporation's Common Stock pursuant to a C 
               Corporation stock option plan to be adopted by the C Corporation 
               at the time  of  the  merger  (the "C Corporation Options").
               The C Corporation stock option plan shall have substantially 
               the same provisions (as determined by the Board  of  Directors
               of  the  C Corporation) as the LLC Option Plan and the 
               Corporation) as the LLC Option Plan and the 
               economic terms of the replacement C Corporation Options shall
               be substantially similar to the economic terms of the LLC 
               Options including the exercise 
               price of  such  replacement C Corporation Options and the extent 
               of vesting thereof.

     (b) The terms and conditions contained in Sections 1.1, 2.2, 3.1 and
3.2  and  those contained in Articles 4, 5, 6, 7, 9 and 10 (other than Section
10.7(a)) of this Agreement 
<PAGE>  22

shall survive the merger and shall be applicable to the  C  Corporation  after  
the  merger  with  references  to  the LLC in such provisions  being  
thereafter  deemed  to  refer  to  the  C  Corporation.
     

     6.3.   COORDINATION  OF  FINANCIAL  REPORTING.
     ----------------------------------------------
     For  so  long as either Incyte, SB or any relevant Incyte Affiliate or SB
Affiliate  reports  the  LLC's financial results (any such reporting entity, a
"Reporting  Entity")  on a consolidated basis, on an equity basis or otherwise
on a basis pursuant to which a portion of the results of operations of the LLC
appear  in  the  financial  results of operations of a Reporting Entity, then:

     (a) The LLC will have its independent auditors perform annual audits of
the  LLC  financial  statements.   The independent auditors' annual audit will
include a review of the financial information the LLC submits to any Reporting
Entity  on  an  annual basis and a statement to any Reporting Entity that
they  have  performed  such review, which will include a detail of any and all
financial  reporting issues noted.  The LLC shall use its best efforts to have
its  independent  auditors  complete  any  audit of the LLC's annual financial
statements  and  deliver  final  financial  statements  (without notes) to the
Reporting  Entities  within  10    Business  Days of the end of the applicable
fiscal  year  and deliver its final audit report complete with notes within 30
Business Days of the end of such fiscal year.  The LLC will keep any Reporting
Entity  informed  as  to  the  timing  and  issues  relating to such financial
statements  on  an  ongoing  basis.

     (b)  Without the prior consent of any relevant Reporting Entity, the LLC
will  not  change  its  fiscal  year  end.

     (c)  The LLC shall provide each Reporting Entity with all financial and
other  related  information  reasonably requested by such Reporting Entity and
any  corresponding  auditors  or Governmental Authority (including information
deemed  reasonably  necessary  by  any  such  entity  to any obligations under
Applicable  Law)  on  a  timetable  to  be agreed upon and made a part of this
Agreement  as  may  be  agreed  to  from  time  to time by the parties hereto.

     (d)  The LLC shall employ an audit firm that is one of the six largest
independent  auditing firms (based on audit employees) in the United States to
perform an annual independent audit of its financial statements; provided that
the  LLC  shall  use a firm which is reasonably satisfactory to Incyte and SB.

     (e)  Representatives of Incyte or SB may, at the request and expense of
Incyte  or SB, as the case may be, perform financial reviews of the LLC, on an
approximately  quarterly  basis,  at  a  mutually convenient time at the LLC's
executive  offices,  for  the  purpose  of  reviewing  the  following:

          (i)    bank  reconciliations  and  cash  investments;

          (ii)   payroll  and  employee  benefits;
 
          (iii)  travel  and  entertainment  expenses;
<PAGE>  23

          (iv)   contracts;  and
 
          (v)    other financial information reasonably requested by Incyte or 
                 SB as the  case  may  be.
   
     6.4.   ADDITIONAL  FINANCING.
     -----------------------------
     The  parties  agree  that  it  may become necessary for the LLC to obtain
third-party  financing, which may take the form of an initial public offering.
In  such  event,  the  parties  agree  to  cooperate  in  the  pursuit of such
third-party  financing,  it  being  understood that any decision to complete a
particular  financing  shall  be  made  by  the parties in their discretion in
accordance  with  the  terms  of  the  LLC  Operating  Agreement.


                                     ARTICLE 7.
                                     ----------
                           EMPLOYEES AND EMPLOYEE BENEFITS
                           -------------------------------
     7.1.   OFFERS  OF  EMPLOYMENT.
     ------------------------------
     Within  sixty  (60) days after the Closing, designated representatives of
the LLC shall have been given the opportunity by SB to interview all of the SB
Employees  and offers of employment shall be given by the LLC to all of the SB
Employees.  Offers to the SB Employees shall provide for employment commencing
on  a  date  or dates determined by the parties.  The LLC will promptly notify
each  party  of  acceptance  of  any  such  offer by any such SB Employee that
becomes  a  Transferring  Employee.   SB shall be responsible for advising its
Transferring  Employees  of  the  details  of any offers and for answering any
questions  relating  thereto.
     
     7.2.   BENEFITS.
     ----------------
     Upon commencement of employment, Transferring Employees shall be eligible
to  participate in the employee benefit plans and other fringe benefits of the
LLC  (subject  to  the terms and conditions of such plans and benefits) on the
same  basis as such plans and benefits are offered to new employees of the LLC
with  comparable  positions  with  the LLC.  For purposes of this Section 7.2,
"employee  benefit  plans  and  other  fringe  benefits"  includes,  without
limitation, qualified retirement plans, retirement and post retirement welfare
benefits,  health insurance benefits (medical, dental and vision), disability,
life  and accident insurance, sickness benefits, and vacation as determined by
the  LLC.

     7.3.   SEVERANCE  PAY.
     ----------------------
     SB  shall  be  responsible  for severance pay and similar obligations, if
any,  that  become  payable  under  SB severance policies as the same shall be
established  from  time  to  time to any SB Employee who is not a Transferring
Employee.
<PAGE>  24

     7.4.   RELOCATION  EXPENSES.
     ----------------------------
     SB  shall  be responsible for any relocation expenses that are offered to
Transferring  Employees  accepting employment with the LLC that are offered to
such  Transferring  Employees.

     7.5.   WAGES,  BENEFITS,  ETC.
     ------------------------------
     (a) SB  shall  be  responsible for timely payment as required by
Applicable Law of all wages, salaries, bonuses, if any, vacation benefits, and
other  compensation  and  benefits  accrued by its Transferring Employees with
respect  to service completed on or prior to such Transferring Employee's last
date  of  employment  by  SB.

     (b) To the extent of commitments that are made to Transferring Employees
in  the  LLC's  offers  of  employment, the LLC shall credit such Transferring
Employees  for  their  length  of service with SB or any SB Affiliates for all
purposes under any 401(k) and vacation plans to be provided by the LLC to such
Transferring  Employees.

     (c) The  LLC  shall  assume  liability  for severance pay and similar
obligations  payable to any Transferring Employee who is terminated by the LLC
after  the date employment commences with the LLC.  Such payment shall be made
pursuant to the LLC's severance policy and the LLC shall compute severance pay
by  giving  all  Transferring  Employees  full credit for all years of service
since  their  date  of  last  hire  with  SB.

     7.6.   PAYMENT  OF  CLAIMS.
     ---------------------------
     All  medical,  dental,  vision, health, sick pay, salary continuation and
disability  claims  incurred  by  Transferring  Employees  with respect to the
period  ending  on  or  prior  to  the  last date of employment by SB shall be
determined  under  SB's  benefit plans, and the LLC shall not assume liability
with  respect  to such claims.  All medical, dental, vision, health, sick pay,
salary  continuation and disability claims incurred with respect to the period
after  the  Transferring Employee's employment commences with the LLC shall be
determined  under  the  LLC's  benefit  plans  and neither SB nor Incyte shall
assume  liability  with respect to such claims (except, in the case of SB, for
any  claims  that may be available under SB's health plan by virtue of Section
4980B  of  the  Code),  but  only  to  the  extent  that  such provision makes
continuation of SB's health plan applicable to any Transferring Employee after
the  last  date of employment by SB.  For all medical, dental, vision, health,
sick  pay,  salary continuation and disability claims incurred with respect to
any  period  of time during which a Transferring Employee is covered under the
LLC's  benefit  plans  as well as SB's benefit plans, the LLC's plans shall be
primary.

     7.7.   SECONDMENT  OF  EMPLOYEES.
     ---------------------------------
     SB may allow certain SB Employees to commence performing services for the
LLC  prior  to  commencement of employment by the LLC.  Any such secondment of
employees  to  the  LLC by SB shall be on terms and conditions to be agreed by
the  LLC  and  SB.
<PAGE>  25

     7.8.   CONTINUING  EMPLOYEES.
     -----------------------------
     Notwithstanding  any  terms  of  this  Article  7  to  the  contrary,  no
Transferring  Employees  shall  be third party beneficiaries of this Article 7
and  the  LLC shall have the sole right to enforce any terms of this Article 7
against  SB  and  SB  shall  have  the sole right to enforce any terms of this
Article  7  against  the  LLC.


                                     ARTICLE 8.
                                     ----------
                                 CLOSING PROCEDURE
                                 -----------------

     8.1.   CLOSING  DATE  AND  PLACE.
     ---------------------------------
     The closing for the transactions provided for herein (the "Closing") will
be  held  at  the  offices  of Morrison & Foerster llp, 425 Market Street, San
Francisco,  California concurrently with the execution of this Agreement or at
such  other  location  and/or  time  as  the  parties  may  agree.


                                     ARTICLE 9.
                                     ----------
                                  INDEMNIFICATION
                                  ---------------
     9.1.   INDEMNIFICATION.
     -----------------------
     (a) Subject to Section 10.1, Incyte shall indemnify and hold harmless
the  LLC,  SB  and each of SB's Affiliates from and against any and all Losses
resulting from any claim, demand, action or other proceeding which any of them
may  suffer,  incur or sustain to the extent arising out of or attributable to
(i)  any  material  breach of any representation or warranty made by Incyte in
Article  4  of this Agreement, (ii) any material breach of any agreement to be
performed  by  Incyte  pursuant to this Agreement, (iii) any actual or alleged
Liability  of  Incyte  that  relates  to the Business or the LLC (other than a
Liability  or  Loss  for  which SB owes Incyte a duty of indemnification under
Section  9.1(b)  or  any  of  the  Related  Agreements  or a Liability that is
otherwise  the  responsibility  of  SB  by  the terms of this Agreement or the
Related  Agreements),  for  the  period  on  or  prior to the Closing and (iv)
one-half  of  any  Unreimbursed  LLC  Liability.   No covenant or agreement of
Incyte  relating  to the representations and warranties made by Incyte, or any
other  disclosure  of  information  by  Incyte  to  SB  (including any alleged
non-disclosure,  incomplete  disclosure,  inaccurate  disclosure,  misleading
disclosure  or  other similar problem), shall constitute the basis for a claim
by  the  LLC, SB or any SB Affiliate under any provision of this Agreement (or
otherwise)  except  under Subsection 9.1(a)(i).  The foregoing is not intended
to  limit  the covenant obligations of the parties under this Agreement or the
remedies  available  to  any party for breach of a covenant so long as, and to
the  extent  that,  the  claim  for  breach  is  not  based  upon  alleged
non-disclosure, incomplete disclosure, misleading disclosure, or other similar
problems.
<PAGE>  26

     (b) Subject to Section 10.1, SB shall indemnify and hold harmless, the
LLC,  Incyte  and  each  of  Incyte's  Affiliates from and against any and all
Losses  resulting from any claim, demand, action or other proceeding which any
of  them  may  suffer,  incur  or  sustain  to  the  extent  arising out of or
attributable to (i) any material breach of any representation or warranty made
by  SB  in  Article  5  of  this  Agreement,  (ii)  any material breach of any
agreement  to  be performed by SB pursuant to this Agreement, (iii) any actual
or  alleged  Liability  of  SB  that  relates  to the Business, the LLC or the
Equipment  (other  than a Liability or Loss for which Incyte owes SB a duty of
indemnification  under  Section  9.1(a)  or any of the Related Agreements or a
Liability  that is otherwise the responsibility of Incyte by the terms of this
Agreement  or  the  Related  Agreements),  for  the  period on or prior to the
Closing,  and (iv) one-half of any Unreimbursed LLC Liability.  No covenant or
agreement  of SB relating to the representations and warranties made by SB, or
any  other  disclosure  of  information by SB to Incyte (including any alleged
non-disclosure,  incomplete  disclosure,  inaccurate  disclosure,  misleading
disclosure  or  other similar problem), shall constitute the basis for a claim
by  the  LLC,  Incyte  or  any  Incyte  Affiliate  under any provision of this
Agreement  (or otherwise) except under Subsection 9.1(b)(i).  The foregoing is
not  intended  to  limit  the  covenant  obligations of the parties under this
Agreement  or  the remedies available to any party for breach of a covenant so
long  as,  and  to  the  extent  that,  the claim for breach is not based upon
alleged non-disclosure, incomplete disclosure, misleading disclosure, or other
similar  problem.

     (c) Subject to Section 10.1, the LLC shall indemnify and hold harmless,
each  of  Incyte,  SB and their respective Affiliates from and against any and
all  Losses  resulting from any claim demand, action or other proceeding which
any  of  them  may  suffer,  incur or sustain  to the extent arising out of or
attributable to (i) any material breach of any representation or warranty made
by  the  LLC, (ii) any material breach of any agreement to be performed by the
LLC  pursuant  to this Agreement, and (iii) any actual or alleged Liability of
the  LLC (other than a Liability or Loss for which Incyte or SB owes the LLC a
duty  of indemnification under Section 9.1(a) or Section 9.1(b), respectively,
or  under  any  of the Related Agreements or a Liability that is otherwise the
responsibility  of  Incyte  or  SB,  as  the case may be, by the terms of this
Agreement  or  the  Related  Agreements).

     (d) No investigation by an Indemnified Party (defined below) at or prior
to  the  Closing shall relieve any Indemnitor (defined below) of any liability
hereunder.    The  waiver  of  any  condition  based  on  the  accuracy of any
representation  or  warranty,  or  based upon the performance of or compliance
with  any  covenant  or obligation, will exclude the right to indemnification,
reimbursement  or  other  remedy  based  upon  such  representation, warranty,
covenant  and  obligation  (to  the  extent so waived), and each party to this
Agreement  shall be required to disclose all known breaches of representations
and  warranties  of  the  other  as  of the date hereof in a certificate to be
delivered  at  the  Closing.

     (e) The  indemnification  remedies provided to the parties under this
Article 9 are intended to be cumulative to any other available remedies except
that  any claim for indemnification within the terms of any IP Agreement shall
be  governed  solely  by such IP Agreements and may not be asserted under this
Agreement.


     9.2.   PROCEDURE  FOR  INDEMNIFICATION.
     ---------------------------------------
     (a) If there is asserted any third party claim, demand, action or
other  proceeding  and in the judgment of the party hereto that is entitled to
indemnification  under  this  Agreement  (the "Indemnified Party") such claim,
demand,  action  or other proceeding may give rise to any Losses indemnifiable
pursuant  to  this  Article  9,  or  if  the  Indemnified Party determines the
existence  of the foregoing, whether or not the same shall have been asserted,
such Indemnified Party shall give the party from whom indemnity is sought (the
"Indemnitor") written notice within thirty (30) Business Days of the assertion
of  the  claim,  demand, action or other proceeding or, if earlier, within ten
(10)  Business  Days  of  receipt of notice of the filing of any lawsuit based
upon  such assertion, or, with respect to a claim not yet asserted against the
Indemnified  Party, promptly upon the determination by an executive officer of
the  Indemnified  Party  of  the  existence  of  the  same.

     (b) With respect to any claim, demand, action or other proceeding asserted
by a third party, the Indemnified Party shall give the Indemnitor a reasonable
opportunity  of  assuming  the  defense of such claim, demand, action or other
proceeding  using  counsel  reasonably  acceptable  to  the Indemnified Party;
provided,  however,  that  the  Indemnified  Party  shall  have  the  right to
participate  in  such  defense,  except  that if the Indemnified Party retains
separate  counsel, other than in the event of a conflict of interest requiring
the  retention of separate counsel, the Indemnified Party shall assume and pay
the  fees  and  expenses  of the separate counsel.  If the Indemnitor fails to
assume  the defense or to contest in good faith any such claim, demand, action
or  other  proceeding  the  Indemnified  Party shall have the right to defend,
settle  or  pay  the  same  and  pursue  its  remedies  against the Indemnitor
hereunder.

     (c) Failure by the Indemnified Party to give timely notice pursuant to
this  Section  shall  not relieve the Indemnitor of its obligations, except to
the  extent  that the Indemnitor is actually and materially prejudiced by such
failure  to  give  timely  notice.   No settlement or adjustment shall be made
without the Indemnified Party's prior written consent, which consent shall not
be  unreasonably  withheld  or  delayed.

     (d) The  Indemnified Party shall, in connection with a claim, demand,
action  or  other  proceeding  asserted  by  a third party, cooperate with the
Indemnitor  in  any  defense  which the Indemnitor assumes as described above;
provided  that,  the Indemnitor shall hold the Indemnified Party harmless from
all  of  its  out-of-pocket  expenses, including attorneys' fees and expenses,
incurred  in  connection  with  the  Indemnified  Party's  cooperation.    The
Indemnified  Party  shall  cooperate  with  the  Indemnitor  in all reasonable
respects in connection with such defense including by providing, to the extent
relevant  to  such  claim (i) prompt access to computer systems, compilations,
historical  data  and other information related to the LLC; (ii) copies of all
books  and  records  related  to  the  LLC; (iii) access to relevant personnel
related  to the LLC; and (iv) generating records, data, compilations and other
required support related to the LLC that is necessary to assist the Indemnitor
in reducing its indemnification obligation.  No settlement or adjustment shall
be made without Indemnitor's prior written consent, which consent shall not be
unreasonably  withheld  or  delayed.
<PAGE>  27

     (e) Notwithstanding anything contained elsewhere in this Section 9.2, if
an  offer  of compromise is received by the Indemnitor with respect to a third
party  claim,  demand, action or other proceeding related to any of the Losses
pursuant to this Article 9, the Indemnitor may notify the Indemnified Party in
writing  of  the  Indemnitor's willingness to compromise or settle such claim,
demand,  action  or  other proceeding on the basis set forth in such notice at
the  sole  expense  of the Indemnitor, and with no further Losses or Liability
to,  or  other  continuing obligation on the part of, the Indemnified Party or
with  respect  to  the Business or the Equipment, except as set forth below in
this  paragraph.   If the Indemnified Party declines to accept such compromise
or  settlement,  the  Indemnified  Party  may  assume  control and continue to
contest  such  claim,  demand,  action  or  other  proceeding  free  of  any
participation  by the Indemnitor, at the Indemnified Party's sole expense.  In
such  event,  the  obligation  of the Indemnitor to the Indemnified Party with
respect  to  such  claim, demand, action or other proceeding shall be equal to
the  lesser of:  (i) the amount of the offer of compromise or settlement which
the  Indemnified  Party  declined  to  accept  and  the amount of any expenses
incurred  prior to such offer of compromise or settlement, and (ii) the actual
Losses  of  the  Indemnified  Party  as  a  result  of the Indemnified Party's
continuing  to  contest  such  claim, demand, action or other proceeding.  The
Indemnitor  shall,  in  connection with such continued contest of the relevant
claim,  demand,  action  or  other  proceeding, cooperate with the Indemnified
Party  in  such  continued contest; provided that, the Indemnified Party shall
hold the Indemnitor harmless from all of its out-of pocket expenses, including
reasonable  attorneys'  fees  and  expenses,  incurred  in connection with the
Indemnitor's  cooperation after the offer of compromise or settlement had been
made.    The  Indemnitor  shall  cooperate  with  the Indemnified Party in all
reasonable  respects  in  connection  with such continued defense including by
providing,  to  the  extent  relevant  to  such  defense  (i) prompt access to
computer  systems, compilations, historical data and other information related
to  the  defense; (ii) copies of all books and records related to the defense;
(iii) access to relevant personnel related to the defense; and (iv) generating
records,  data, compilations and other required support related to the defense
that  is  necessary  to assist the Indemnified Party in reducing its Liability
for  any  Losses  not  covered  by  the  indemnification.

     (f) The Indemnitor shall, in connection with a claim, demand, action or
other  proceeding  asserted by a third party, keep the Indemnified Party fully
informed  in  connection  with  any  defense  which  the Indemnitor assumes as
described above whether or not the Indemnified Party chooses to be represented
by  separate  counsel.


                                    ARTICLE 10.
                                    -----------
                                  MISCELLANEOUS
                                  -------------
     10.1.  SURVIVAL.
     ----------------
     The  parties' respective representations and warranties contained in this
Agreement  shall  survive  after  the  Closing.  Any claim for indemnification
pursuant  to  Section  9.1(a)(i)  or  9.1(b)(i)  in  respect  of breach of any
representations  and  warranties  must  be  commenced  in  compliance with the
requirements contained in Section 9.1.  EXCEPT AS SET FORTH IN THIS 
<PAGE> 28

AGREEMENT,(A)  NEITHER  INCYTE  NOR  ANY OF ITS REPRESENTATIVES OR EMPLOYEES 
HAS MADE OR MAKES  ANY EXPRESS OR IMPLIED WARRANTY TO SB OR THE LLC AND (B) 
NEITHER SB NOR ANY  OF  ITS  REPRESENTATIVES  OR  EMPLOYEES  HAS MADE OR MAKES 
ANY EXPRESS OR IMPLIED  WARRANTY  TO  INCYTE  OR  THE  LLC.  THE WARRANTIES SET 
FORTH IN THIS AGREEMENT  ARE IN LIEU OF, AND EXCLUDE, AND SB, INCYTE AND THE 
LLC EACH HEREBY WAIVES, ANY OTHER WARRANTY FROM, OR IN CONNECTION WITH THE 
CONTRIBUTION OF THE ASSETS  HEREUNDER,  OR  THE  USE OR PERFORMANCE THEREOF, 
INCLUDING ANY IMPLIED WARRANTY  OF  MERCHANTABILITY,  OR  FITNESS  FOR A 
PARTICULAR PURPOSE, AND ANY IMPLIED  WARRANTY  ARISING  FROM  COURSE  OF  
DEALING  OR  USAGE  OF  TRADE.

     10.2.  NO  COMMITMENTS.
     ------------------------
     No  party  shall  incur  any debts or make any commitments for the other,
except  to  the  extent,  if  at  all,  specifically  provided  herein.

     10.3.  ASSIGNMENTS.
     --------------------
     This  Agreement  shall  be  binding  upon and inure to the benefit of the
successors  in interest of the respective parties.  Neither this Agreement nor
any  interest  hereunder shall be assigned or transferred, whether directly or
indirectly,  including  by operation of law ("Assign" or "Assignment"), by any
party  without  the  prior  express  written  consent  of  the  other parties;
provided,  however,  that either Incyte or SB may Assign this Agreement or any
of  its  rights  or  obligations  hereunder:
     
     (a) To any of its direct or indirect subsidiaries, provided that (i)
Incyte  or  SB,  as  the  case  may  be,  shall  own,  directly or indirectly,
securities  of  such  subsidiary  that  enable  it  to elect a majority of the
directors  of  such  subsidiary  and  any minority interest in such subsidiary
shall  be  widely  held  and no single holder of a minority interest shall own
beneficially  (within the definition set forth in Rule 13d-3 of the Securities
Exchange  Act of 1934) securities representing more than 10% of the securities
of such subsidiary entitled to vote generally for the election of directors or
other  persons  performing  similar functions (a "Majority-Owned Subsidiary"),
and  (ii) should such subsidiary no longer be a Majority-Owned Subsidiary, the
rights  and  obligations of such subsidiary pursuant to this Agreement and the
LLC Operating Agreement shall be transferred back to Incyte or SB, as the case
may  be  (or  to another direct or indirect subsidiary of Incyte or SB, as the
case  may be, to which such party could transfer the rights and obligations of
such  subsidiary  pursuant  to  this Agreement and the LLC Operating Agreement
consistent  with  the  terms  of  this  subsection  (a));

     (b) To  an entity that owns 100% of the securities or other ownership
interests having ordinary voting power to elect the directors or other persons
performing  similar  functions  of  Incyte  or  SB,  as  the  case  may be; or
     
     (c) To an entity of which the securities or other ownership interests
having  ordinary  voting  power  to  elect  the  directors  or  other  persons
performing  similar  functions  are  
<PAGE>  29

owned  100%  by  an  entity  that  owns beneficially,  directly  or  
indirectly, 100%  of  the  securities  or  other ownership  interest  having
ordinary voting  power to elect the directors or other persons performing 
similar functions of Incyte or SB as the case may be.  Notwithstanding the 
foregoing, no party shall be prohibited from completing an Assignment  that
occurs  through (and  as  a  direct  result of) a Change of Control.   Any 
Assignment made pursuant to this Section shall be valid only if(A)  the  
assigning  party  remains  liable  under  this Agreement and the LLC 
Operating  Agreement,  and (B) the relevant subsidiary or other entity 
assumes in  writing  all of the assigning party's obligations under this 
Agreement and the  LLC  Operating  Agreement.  Any purported Assignment in 
violation of this Section  10.3  shall  be  void.

     10.4.   CONFIDENTIALITY.
     -----------------------
     (a) Each party acknowledges that pursuant to this Agreement, the LLC
Operating  Agreement,  the  Intercompany  Services  Agreement  or otherwise in
connection  with the relationships between the parties contemplated hereunder,
such  party  (the  "Receiving Party") will receive from other parties or their
Affiliates  disclosure of information that is proprietary, confidential and of
commercial  value  to  the  disclosing  party  (the  "Disclosing Party").  For
purposes of this Section 10.4, "Confidential Information" shall mean technical
and  business information belonging to the Disclosing Party which is disclosed
pursuant  to  this  Agreement  or the LLC Operating Agreement, including where
appropriate  and  without limitation, any information, business, financial and
scientific  data  and  the like.  Except to the extent expressly authorized by
this  Agreement,  each  Receiving Party agrees that, until the dissolution and
winding-up  of  the LLC and for ten (10) years thereafter, it shall on its own
behalf,  and shall cause any affiliated Reporting Entity to, keep confidential
and  shall not publish or otherwise disclose and shall not use for any purpose
(except  those  expressly  permitted  under  this  Agreement) any Confidential
Information  furnished  to  it  by  a  Disclosing Party, and regardless of the
medium  on  which  it  is  provided,  pursuant  to  this  Agreement or the LLC
Operating  Agreement,  including know-how, except to the extent that it can be
established  by  the Receiving Party by competent proof that such information:

          (i)   was  already  known to it, other than under an obligation of
                confidentiality,  at  the  time  of  disclosure  by  the  
                Disclosing  Party;

          (ii)  was generally known to the public or otherwise part of the 
                public domain  at  the  time  of  its  disclosure  to  the  
                Receiving  Party;

          (iii) became generally available to the public or otherwise part of 
                the public  domain  after its disclosure other than through any 
                act or omission of it  in  breach  of  this  Agreement  or  the 
                LLC  Operating  Agreement;

          (iv)  was  subsequently  lawfully disclosed to it by a third party; or
 
          (v)   was independently discovered or developed by it without the use 
                of the Disclosing  Party's  Confidential Information, as can
                be documented by written records  created  at  the  time  of
                such independent discovery or development.
<PAGE>  30

          (vi)  Notwithstanding Section 10.4(a), the Receiving Party may 
                disclose the other  party's  Confidential  Information  to  the 
                extent  such disclosure is reasonably  necessary in complying 
                with Applicable Law; provided however, that if  a  Receiving 
                Party or a Receiving Party's affiliated Reporting Entity, is
                required  to  make  any  disclosure  of  the  Disclosing
                Party's Confidential Information, the Receiving Party or such 
                affiliated Reporting Entity will give reasonable  advance  
                written notice to the Disclosing Party of such disclosure
                requirement  and  will  use  its  reasonable  efforts  to
                secure confidential treatment  of  such  information  required 
                to  be  disclosed.

     (b) Notwithstanding Section 10.4(a), no party shall make any public
announcements  or  issue  any  press  release  concerning  any  aspect  of the
Business, the relationship of the parties pursuant to this Agreement or any of
the  Related  Agreements  or  any  other  matter  incidental  to the foregoing
including  any  announcement  that references the name of another party except
(i)  any  disclosure that has been agreed to by the parties, including routine
or  recurring disclosures of agreed upon statements; (ii) disclosures required
by  Applicable  Law  so long as the text of any such disclosure is provided to
the  other  parties  for comment and review at least five (5) Business Days in
advance of disclosure; and (iii) disclosures of material financial information
in  a  press  release  that  relates  to  a  party's  earnings  or  financial
performance,  so  long  as  the text of any such disclosure is provided to the
other  parties for comment and review at least one (1) Business Day in advance
of  disclosure.

     (c) The  terms of Sections 10.4(a) and 10.4(b) shall not apply to any
matters  covered  by  the  confidentiality  provisions  contained  in  the  IP
Agreements.

     10.5.   INTENTIONALLY  OMITTED.
     -------------------------------
     10.6.  OBSERVANCE  OF  SEPARATE  ENTITY  FORMALITIES
     -----------------------------------------------------
     The  LLC  shall  establish and comply with a set of financial, accounting
and  corporate  policies  that  (A)  observe its character as a separate legal
entity  from  each  of  Incyte  and  SB,  (B)  are  similar to those generally
established  by  companies  comparable  to  the  LLC,  and  (C) are reasonably
satisfactory  to Incyte and SB.  Areas to be addressed by these policies shall
include  (without  limitation):

          (i)   cash management policies and cash investment guidelines which  
                shall be on terms and conditions established comparable to 
                those that would apply in an arms'  length  transaction,  
                including that  all  funds  are  accounted  for separately  
                unless otherwise  agreed  to  by  the  parties;

          (ii)  levels of authorization and approval by management and the 
                Board of Directors  for purchases, contracts, check signing,
                wire transfers and capital commitments;

          (iii) normal accounting procedures in accordance with generally 
                accepted accounting  principles  consistently applied including 
<PAGE>  31               

                accrual and recognition of  expenses,  depreciation,  revenue 
                recognition;  and

          (iv) observing  all  other  required formalities of law for a limited
               liability  company  including  holding  any  required meetings
               of its managing board  or  other  governing  body,  as  well  
               as meetings  of  holders of its membership  interests  in  each  
               case  in  accordance  with  the LLC Operating Agreement.

     10.7.  CERTAIN  DISSOLUTION  MATTERS.
     --------------------------------------
     Upon  the dissolution of the LLC pursuant to the LLC Operating Agreement,
the  following  additional  terms  and  conditions  shall govern to the extent
applicable  in  connection  with  the  dissolution:

     (a) Except as otherwise agreed to by Incyte and SB, to the extent
that  the  Collaboration  and License Agreement has terminated pursuant to the
material  breach  or  bankruptcy  provisions of such Collaboration and License
Agreement, all DiaDexus IP (all terms in this Section 10.7 not defined in this
Agreement  shall  have the meanings set forth in the Collaboration and License
Agreement)  with  respect to such dissolution shall be distributed as follows:

          (i)   [                                                      ].

          (ii)  [                                                      ].

     (b) All other assets of the LLC, including DiaDexus IP governed by
Section  10.7(a)(ii),  shall be governed by such dissolution procedures (i) in
accordance  with the LLC Operating Agreement or as SB and Incyte may otherwise
agree  are appropriate at the time; or (ii) as may otherwise be provided under
Applicable  Law.    Incyte  and  SB shall use their respective best efforts to
reach  agreement  on  the  distribution of all assets of the LLC, and any such
agreement  will  be  given  precedence,  to the maximum extent permitted under
Applicable  Law,  over procedures that might otherwise apply under the Act (as
defined in the LLC Operating Agreement) or under any other Applicable Law.  As
between  Incyte  and  SB, each agrees to proceed in good faith in the event of
any  dissolution  of  the LLC in order to fulfill the purposes of this Section
10.7  and  the LLC Operating Agreement and neither shall seek a dissolution of
the  LLC  in  accordance with the material breach provisions of Section 9.1 of
the  LLC Operating Agreement in the absence of a breach that is fundamental to
the  essential  purposes  or  operation  of  the  LLC.
<PAGE>  32

      (c) The terms and conditions contained in Sections 1.1, 3.1 and 6.3 and
those  contained in Articles 4, 5, 7, 9 and 10 of this Agreement shall survive
dissolution  of  the  LLC  (other  than  a  merger  governed  by Section 6.2).

      (d) The parties intend that the terms of Section 10.7(a) be and hereby is
incorporated  by  reference  into  and  made  a  part of the Collaboration and
License  Agreement.

     10.8.  FURTHER  ACTIONS.
     -------------------------    
     Each  party  agrees  to  execute,  acknowledge  and  deliver such further
instruments, and to do all such other acts, as may be necessary or appropriate
in  order  to  carry  out  the  purposes  and  intent  of  this  Agreement.

     10.9.  NO  TRADEMARK  RIGHTS.
     ------------------------------
     Except  as  otherwise  provided  herein, no right, express or implied, is
granted  by  this Agreement to use in any manner the names "SmithKline Beecham
Corporation,"  "Incyte Pharmaceuticals, Inc." or "DiaDexus, LLC", or any other
trade name or trademark of SB, Incyte or LLC or their Affiliates in connection
with  the  performance  of  this  Agreement.

     10.10. ENTIRE  AGREEMENT  OF  THE  PARTIES;  AMENDMENTS.
     --------------------------------------------------------  
     This  Agreement  and  the  Related  Agreements constitute and contain the
entire understanding and agreement of the parties and cancel and supersede any
and  all  prior  negotiations, correspondence, representations, understandings
and  agreements, whether verbal or written, between the parties respecting the
subject  matter  hereof.  The terms of the LLC Operating Agreement will govern
in  the  event  of  any  inconsistent  terms  of  this  Agreement.  No waiver,
modification or amendment of any provision of this Agreement shall be valid or
effective  unless  made  in writing and signed by a duly authorized officer of
each  of  the  parties.

     10.11. SEVERABILITY.
     --------------------
     In  the  event any one or more of the provisions of this Agreement should
for any reason be held by any court or authority having jurisdiction over this
Agreement (including arbitrators) or any of the parties to be invalid, illegal
or unenforceable, such provision or provisions shall be validly reformed to as
nearly as possible approximate the intent of the parties and, if unreformable,
shall be divisible and deleted in such jurisdiction; elsewhere, this Agreement
shall  not  be  affected  so long as the parties are still able to realize the
principal  benefits  bargained  for  in  this  Agreement.

     10.12. CAPTIONS.
     ----------------
     The captions to this Agreement are for convenience only, and are to be of
no force or effect in construing or interpreting any of the provisions of this
Agreement.
<PAGE>  33

     10.13.  APPLICABLE  LAW.
     ------------------------
     Notwithstanding  the place where this Agreement may be executed by any of
the  parties  hereto,  the  parties  expressly  agree  that  all the terms and
provisions  of  this  Agreement  and the rights and liabilities of the parties
hereto  shall  be governed by and construed in accordance with the laws of the
State  of  Delaware.

     10.14. DISCLAIMER.
     ------------------
     EXCEPT  AS  EXPLICITLY  STATED  HEREIN  NO  PARTY  WILL  BE  LIABLE  FOR
CONSEQUENTIAL  OR  INCIDENTAL  DAMAGES OF ANY NATURE ARISING FROM SUCH PARTY'S
ACTIVITIES UNDER THIS AGREEMENT; PROVIDED, HOWEVER, THAT THIS LIMITATION SHALL
NOT  LIMIT  THE INDEMNIFICATION OBLIGATION OF SUCH PARTY UNDER ARTICLE 9 ABOVE
FOR  CONSEQUENTIAL  OR  INCIDENTAL  DAMAGES  RECOVERED  BY  A  THIRD  PARTY.

     10.15. NOTICES  AND  DELIVERIES.
     --------------------------------
     All  notices,  requests, demands, consents and other communications given
or  required  to be given under this Agreement and under the related documents
shall  be  in  writing  and  delivered  to the applicable party at the address
indicated  below:

If  to  Incyte:          Incyte  Pharmaceuticals,  Inc.
                         3174  Porter  Drive
                         Palo  Alto,  CA  94304
                         Attention:    Chief  Executive  Officer
                         Tel:  (650)  855-0555
                         Fax:  (650)  845-4500

If  to  SB:              SmithKline  Beecham  Corporation
                         709  Swedeland  Road
                         P.O.  Box  1539
                         King  of  Prussia,  PA  19406
                         Attention:    John  Keller
                         Tel:  (610)  270-5973
                         Fax:  (610)  270-5964
<PAGE>  34

and
                         SmithKline  Beecham  Corporation
                         One  Franklin  Plaza
                         P.O.  Box  7929
                         Philadelphia,  PA  19161
                         Attention:    Donald  F.  Parman
                         Tel:  (215)  751-7633
                         Fax:  (215)  751-5349

If  to  the  LLC:        Address  be  provided  by  notice to Incyte and SB.

and

With  a  copy  to:       each  of  Incyte  and  SB.

or,  as  to  each  party  at such other address as shall be designated by such
party in a written notice to the other party complying as to delivery with the
terms of this Section.  Any notices shall be in writing, including telegraphic
or  facsimile  communication, and may be sent by registered or certified mail,
return  receipt  requested,  postage  prepaid, by fax or by overnight delivery
service.    Notice  shall  be  effective  upon  actual  receipt  thereof.

     10.16. COUNTERPARTS.
     ---------------------
     This Agreement may be executed in two or more counterparts, each of which
shall  be  deemed  an original, but all of which together shall constitute one
and  the  same  instrument.

     10.17. CONSTRUCTION  OF  AGREEMENT.
     ------------------------------------
     SB  and Incyte have jointly participated in the negotiations and drafting
of  this  Agreement.    In  the  event  any ambiguity or question of intent or
interpretation arises, this Agreement shall be construed as if drafted jointly
by  SB  and Incyte and no rule of construction, presumption or burden of proof
shall  arise  favoring one party or the other concerning the interpretation of
ambiguous provisions or otherwise (including under California Civil Code 1654)
by  virtue  of  one  party's  presumed  authorship  of  this  Agreement or any
provision hereof.  The use of the terms "including" or "include" shall, in all
cases,  mean  "including,  without  limitation,"  and  "include,  without
limitation,"  respectively.    The  use  of  the masculine, feminine or neuter
gender  herein  shall,  as  applicable,  also refer to the other genders.  The
terms  "material",  "Material  Adverse  Effect"  and phrases of similar import
shall  be  determined  in  terms  of  the  transactions  contemplated  by this
Agreement  and  not  in terms of the resources of SB or Incyte.  Except as the
context  otherwise  requires,  the  use of the singular form of any term shall
also  refer  to  the  plural,  and  vice  versa.  Unless the context otherwise
requires,  whenever  the terms "hereto," "hereunder," "herein" or "hereof" are
used  in  this  Agreement,  such terms shall be construed as referring to this
entire  Agreement  and  references  to "Articles," "Sections," "introduction,"
"recitals,"  "clauses,"    and  "Schedules" shall be construed as referring to
those  of this Agreement.  Except where the context otherwise requires such as
by  virtue  of a reference to a specific Section 
<PAGE>  35

or Article of this Agreement, references  to  this  Agreement  shall  be deemed 
to include references to the entire  Agreement.    All  references in this 
Agreement to fees or expenses or legal  fees and expenses shall include 
allocated fees and expenses of in-house counsel  and  legal  staff.

     10.18. EXPENSES.
     -----------------
     Unless  specifically  provided  otherwise  in  this Agreement, each party
shall  bear  and  pay  all costs and expenses which it incurs, or which may be
incurred  on  its  behalf in connection with the preparation of this Agreement
and consummation of the transactions described herein, and the expenses, fees,
and  costs necessary for obtaining any Governmental Consents.  Nothing in this
provision  shall alter the manner in which costs and expenses are allocated in
the  LLC  Operating  Agreement  or  the  Intercompany  Services  Agreements.

     10.19.  FORCE  MAJEURE.
     -----------------------
     "Force  Majeure"  shall  mean  an  Act  of  God,  flood, fire, explosion,
earthquake,  strike,  lockout, casualty or accident, war, civil commotion, act
of  public  enemies,  blockage  or  embargo,  or  any  injunction, law, order,
proclamation,  regulation,  ordinance, demand or requirement of any government
or  any  subdivision,  authority  representative  thereof,  or any other cause
whatsoever, whether similar or dissimilar to those enumerated above, which are
beyond the reasonable control of such party, which the party affected has used
its reasonable best efforts to avoid, and which prevent, restrict or interfere
with  the  performance  by  a  party  of its obligations hereunder.  The party
affected  by  Force  Majeure  shall give notice to the other party promptly in
writing  and  whereupon  shall be excused from those obligations hereunder, to
the  extent of such prevention, restriction or interference, provided that the
affected  party  shall  use  its  commercially  reasonable efforts to avoid or
remove  such  cause(s)  of  non-performance  and  shall  continue  performance
whenever  such  cause(s)  is  removed.

     10.20. AFFILIATE  PERFORMANCE.
     -------------------------------
     To  the  extent that any LLC Affiliate has the right to receive any other
rights  or  benefits under this Agreement or otherwise is obligated to perform
any  obligations  under this Agreement, the LLC shall cause such LLC Affiliate
to  perform in full, when due, all applicable obligations under this Agreement
to  the  same  extent as if such LLC Affiliate were a party to this Agreement;
provided,  however, that nothing in this Section 10.20 shall expand the rights
or benefits of the LLC or its LLC Affiliates, or the obligations of Incyte, or
SB  beyond  those  otherwise  expressly  set forth in this Agreement.  The LLC
shall  guarantee  timely performance in full by such LLC Affiliate of all such
obligations.

     10.21. DISPUTE  RESOLUTION.
     ----------------------------
     (a) Any controversy or claim between the parties (other then a claim
for  indemnification  under  any of the Related Agreements), arising out of or
relating  to  this  Agreement  or any of the Related Agreements, or the breach
thereof  or  misrepresentation  thereunder  including  any  disputes regarding
rights of the parties to terminate this Agreement or any Related Agreement, or
whether  any  such  termination has been wrongfully undertaken, shall 
<PAGE>  36

first be submitted  for  resolution  to  a  committee consisting of the chief 
executive officer  of each of the parties involved in such dispute, whether 
they include SB  and  Incyte  or the LLC and either of SB and Incyte, or any 
combination of the  foregoing.    If  the  committee is unable to resolve such 
controversy or claim  within  twenty  (20)  days  of  the  submission  of  such 
matter to the committee,  then  the  parties may have access to any remedies 
available under Applicable  Law  or  otherwise.

     (b) The parties agree that termination of this Agreement or any Related
Agreement  shall  be available in accordance with the terms of such agreement,
but it is the intention of the parties that disputes shall be resolved without
termination  of  an  agreement  to  the  maximum  extent  possible.

     10.22.  RELATIONSHIP  BETWEEN  PARTIES
     --------------------------------------
     (a) Nothing in this Agreement or in any of the Related Agreements
shall  deem  Incyte and SB to be involved in any joint venture or relationship
as  general  partners  and  each of them agrees to take no action inconsistent
with  the  characterization of the LLC as a limited liability company, or as a
corporation  after  the conversion, and the relationship between Incyte and SB
shall be deemed to be solely that of members in the LLC or stockholders in the
corporation.

     (b) Except  to the extent expressly provided herein or in any Related
Agreement,  neither  this  Agreement  nor  any of the Related Agreements shall
constitute an appointment of any of the parties hereto or thereto as the legal
representative  or  agent  of any other party hereto or thereto, nor shall any
party hereto or thereto have any right or authority to assume, create or incur
in  any  manner  any  obligation  or  other  Liability of any kind, express or
implied,  against,  or  in the name or on behalf of, the other party hereto or
thereto.

     10.23. THIRD  PARTY  BENEFICIARIES.
     ------------------------------------
     Except  as  otherwise  agreed by SB and Incyte, the parties hereto intend
that  this  Agreement shall not benefit or create any right or cause of action
in  or  on  behalf  of  any Person other than the parties hereto except to the
extent  specifically  provided  herein.    Without limiting the foregoing, (i)
Article  7  shall  not  be  construed  as conferring any right, entitlement or
benefit  on  any  employee of Incyte, SB or the LLC, and (ii) no Member in the
LLC  shall  have  any  interest  through the LLC in the subject matter of this
Agreement  whether  derivatively  or  otherwise.

     10.24. CERTAIN  TRANSFER  MATTERS.
     -----------------------------------
     No  transfer of an Interest may be made except as contemplated by the LLC
Operating Agreement.  No transfer of an Interest shall relieve the obligations
of  Incyte or SB under this Agreement including the obligation to make capital
contributions to the LLC.  The parties shall cause any transferee of Interests
other  than  an Incyte Affiliate or a SB Affiliate to be bound by the terms of
Sections  6.2,  10.4  and  10.7  and 10.22 of this Agreement (or substantially
comparable  restrictions),  but no such transferee shall have any rights under
this  Agreement.

<PAGE>  37

     IN  WITNESS WHEREOF, the parties, through their authorized officers, have
executed  this  Agreement  as  of  the  date  first  written  above.


SMITHKLINE  BEECHAM  CORPORATION


By: /s/ George Poste
   -------------------------------------------

     Its: Chief Science and Technology Officer
         -------------------------------------

INCYTE  PHARMACEUTICALS,  INC.


By: /s/ Randal W. Scott
   -------------------------------------------

     Its: President
         -------------------------------------

DIADEXUS,  LLC


By: /s/ Patrick Plewman
   -------------------------------------------

Its: Vice President, Corporate Development
    ------------------------------------------

<PAGE>  38

                                SCHEDULE 1.1(a)- SB EQUIPMENT
                                -----------------------------
 

[96 lines deleted from Schedule 1.1(a)]

<PAGE>  39

                                SCHEDULE 1.1(b)- SB EMPLOYEES
                                -----------------------------

[13 lines deleted from Schedule 1.1(b)]



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission